Search results
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 5 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
BioPharma-Reporter· 7 hours agoConsequently commercial demands of many of these next generation therapeutics are lower, ranging...